Historical award
Laulima Government Solutions, LLC
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (24 days old).
Fiscal year 2026: data through (24 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $1,169,925.80
- Potential award value
- $1,169,925.80
- Total obligated to date
- $1,169,925.80
Source date: Oct 14, 2026
Recorded work
COMBINED LONG TERM EFFEROCYTOSIS AND ENHANCED ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY RESPONSE HIV VACCINE CLINICAL TRIAL TO INVESTIGATE SAFETY AND IMMUNOGENICITY OF NEW VACCINE CANDIDATES IN SUPPORT OF THE WAR FIGHTER.
Award activity
- Obligations in covered fiscal years
- $1,169,925.80
- Transactions in covered fiscal years
- 1
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_HT942525FE074_9700_W81XWH19D0011_9700